Chang Yi Wang

1.9k total citations
50 papers, 1.5k citations indexed

About

Chang Yi Wang is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Chang Yi Wang has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Genetics. Recurrent topics in Chang Yi Wang's work include Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (11 papers). Chang Yi Wang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (11 papers). Chang Yi Wang collaborates with scholars based in United States, Taiwan and United Kingdom. Chang Yi Wang's co-authors include James P. Halper, Daniel M. Knowles, Chien C. Chang, Wayne C. Koff, Alan M. Walfield, Karl Welte, Henry G. Kunkel, Derek T. O’Hagan, Tim J. Zamb and Xin Fang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Chang Yi Wang

49 papers receiving 1.3k citations

Peers

Countries citing papers authored by Chang Yi Wang

Since Specialization

Citations

This map shows the geographic impact of Chang Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Yi Wang more than expected).

Fields of papers citing papers by Chang Yi Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Yi Wang. The network helps show where Chang Yi Wang may publish in the future.

Co-authorship network of co-authors of Chang Yi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Yi Wang. A scholar is included among the top collaborators of Chang Yi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Yi Wang. Chang Yi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study 2023 ·EBioMedicine ·Hui Jing Yu, Samuel P. Dickson, Pei‐Ning Wang, Ming‐Jang Chiu, Chin‐Chang Huang, Chiung‐Chih Chang, (unknown), Suzanne Hendrix, Jean‐Cosme Dodart, Ajay Verma, Chang Yi Wang, Jeffrey L. Cummings	32
2	Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut 2021 ·Acta Neuropathologica ·(unknown), Harry Smith, Chang Yi Wang, Jessica L. Teeling, James A. R. Nicoll, Ajay Verma, Jean‐Cosme Dodart, Zhi Liu, Lin Feng, Roxana O. Carare	20
3	Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy 2020 ·Alzheimer s Research & Therapy ·(unknown), Ajay Verma, Jean‐Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll	34
4	Starting electroosmotic flow in an annulus and in a rectangular channel 2008 ·Electrophoresis ·Chien C. Chang, Chang Yi Wang	37
5	Site-specific UBITh® amyloid-β vaccine for immunotherapy of Alzheimer's disease 2007 ·Vaccine ·Chang Yi Wang, Connie L. Finstad, Alan M. Walfield, Charles Sia, (unknown), (unknown), Xin Fang, (unknown), Birgit Hutter‐Paier, Manfred Windisch	76
6	EOF using the Ritz method: Application to superelliptic microchannels 2007 ·Electrophoresis ·Chang Yi Wang, Chien C. Chang	12
7	SARS Antibody Test for Serosurveillance 2004 ·Emerging infectious diseases ·Po‐Ren Hsueh, Chuan‐Liang Kao, Chun-Nan Lee, (unknown), (unknown), Charles Sia, Xin Fang, (unknown), (unknown), (unknown), Alan M. Walfield, Chang Yi Wang	24
8	Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy 2003 ·Vaccine ·Connie L. Finstad, Chang Yi Wang, Jacek Kowalski, (unknown), (unknown), (unknown), Wei Xia, Maarten C. Bosland, Krishna K. Murthy, Alan M. Walfield, Wayne C. Koff, Timothy J. Zamb	20
9	Synthetic AIDS vaccine by targeting HIV receptor 2002 ·Vaccine ·Chang Yi Wang, Ming Shen, (unknown), Xin Fang, (unknown), Fan Shen, Alan M. Walfield, (unknown), (unknown), (unknown), María Salas, Michael H. Shearer, Ronald C. Kennedy, Carl V. Hanson	27
10	Effective synthetic peptide vaccine for foot-and-mouth disease in swine 2002 ·Vaccine ·Chang Yi Wang, (unknown), Alan M. Walfield, (unknown), Ming Shen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ed Kramer, F. Brown	117
11	Synthetic Peptide-based Vaccine and Diagnostic System for Effective Control of FMD 2001 ·Biologicals ·Chang Yi Wang, (unknown), Alan M. Walfield, (unknown), Ming Shen, (unknown), Juan Lubroth, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ed Kramer, F. Brown	16
12	CTL induction using synthetic peptides delivered in emulsions— critical role of the formulation procedure 1997 ·Vaccine ·Manmohan Singh, Catarina E. Hioe, (unknown), (unknown), Chang Yi Wang, Wayne C. Koff, Timothy J. Zamb, Douglas F. Nixon	9
13	Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice 1997 ·Vaccine ·Manmohan Singh, (unknown), John P. McGee, Tim J. Zamb, Wayne C. Koff, Chang Yi Wang, Derek T. O’Hagan	73
14	Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity 1996 ·Vaccine ·Douglas F. Nixon, Catarina E. Hioe, (unknown), (unknown), Peter Kuebler, (unknown), (unknown), (unknown), Manmohan Singh, Julie Richardson, (unknown), Tim J. Zamb, Wayne C. Koff, Chang Yi Wang, Derek T. O’Hagan	114
15	Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides 1996 ·Vaccine ·Catarina E. Hioe, (unknown), (unknown), (unknown), (unknown), (unknown), Manmohan Singh, Peter Kuebler, (unknown), Derek T. O’Hagan, Tim J. Zamb, Wayne C. Koff, Catherine E. M. Allsopp, Chang Yi Wang, Douglas F. Nixon	26
16	Stimulation and Expansion of a Human T-Cell Subpopulation by a Monoclonal Antibody to T-Cell Receptor Molecule 1986 ·Hybridoma ·Chang Yi Wang, Yuri Bushkin, (unknown), C L Lane, Helen McGrath, David N. Posnett	22
17	B-lymphocyte associated differentiation antigen expression by ‘non-B, non-T’ acute lymphoblastic leukemia 1985 ·Leukemia Research ·Frances Flug, (unknown), James A. Wolff, Ludovico Guarini, Aaron R. Rausen, Chang Yi Wang, Daniel M. Knowles	8
18	Phenotypic characterization of ‘non‐T, non‐B’ acute lymphoblastic leukemia by a new panel (BL) of monoclonal antibodies 1985 ·Hematological Oncology ·Ayad Al‐Katib, Chang Yi Wang, Ricardo H. Bardales, Benjamín Koziner	3
19	Preparation and characterization of monoclonal antibodies recognizing two distinct differentiation antigens (Pro-Im1, Pro-Im2) on early hematopoietic cells. 1984 ·Blood ·(unknown), Ayad Al‐Katib, Daniel M. Knowles, Li Lu, Hal E. Broxmeyer, (unknown), Jen-Wei Chiao, Benjamín Koziner, Chang Yi Wang	10
20	The Nature of the Stimulatory Cell in Human Allogeneic and Autologous MLC Reactions; Role of Isolated IgM-Bearing B Cells 1979 ·The Journal of Immunology ·Alice B. Gottlieb, Shu Man Fu, David Tak Yan Yu, Chang Yi Wang, James P. Halper, Henry G. Kunkel	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact